Cite
Clinical performance of AMA‐M2, anti‐gp210 and anti‐sp100 antibody levels in primary biliary cholangitis: When detected by multiplex bead‐based flow fluorescent immunoassay.
MLA
Wang, Zhan, et al. “Clinical Performance of AMA‐M2, Anti‐gp210 and Anti‐sp100 Antibody Levels in Primary Biliary Cholangitis: When Detected by Multiplex Bead‐based Flow Fluorescent Immunoassay.” Immunity, Inflammation & Disease, vol. 12, no. 1, Jan. 2024, pp. 1–10. EBSCOhost, https://doi.org/10.1002/iid3.1161.
APA
Wang, Z., Li, Y., Ren, L., Li, Y., Xu, T., Li, W., Gao, W., Sun, G., & Liu, M. (2024). Clinical performance of AMA‐M2, anti‐gp210 and anti‐sp100 antibody levels in primary biliary cholangitis: When detected by multiplex bead‐based flow fluorescent immunoassay. Immunity, Inflammation & Disease, 12(1), 1–10. https://doi.org/10.1002/iid3.1161
Chicago
Wang, Zhan, Yongxin Li, Lisheng Ren, Yujie Li, Tiantian Xu, Wenshuai Li, Weize Gao, Guirong Sun, and Mingjun Liu. 2024. “Clinical Performance of AMA‐M2, Anti‐gp210 and Anti‐sp100 Antibody Levels in Primary Biliary Cholangitis: When Detected by Multiplex Bead‐based Flow Fluorescent Immunoassay.” Immunity, Inflammation & Disease 12 (1): 1–10. doi:10.1002/iid3.1161.